The alliance shifts the focus of implant dentistry toward the post-operative period, emphasizing that clinical success depends on consistent maintenance rather than just surgical placement. By integrating HuFriedyGroup’s instrument workflows with the ITI’s evidence-based research, the organizations intend to develop practical guidance for clinicians who are currently struggling with the global increase in peri-implant diseases.

Rob Woolley, CEO of HuFriedyGroup, highlighted that the partnership leverages shared expertise to provide clinicians with the tools necessary for preserving patient outcomes over time. Under the terms of the agreement, HuFriedyGroup will join the ITI’s modular sponsorship program, which includes the joint development of symposia, congresses, and specialized educational content. Alexander Ochsner, CEO of the ITI, noted that this structure supports their goal of aligning with industry leaders committed to scientific rigor and professional development. For the 25,000 members of the ITI, this represents a new channel for accessing the technical protocols required to manage the long-term health of dental implants.